Report overview
Implantable pulse generator is a battery-powered micro-electronic medical device that is implanted in the body, delivers electric stimulation to the nervous system in order to stimulate or block various nerve impulses in the body. The technology is adapted from the technology used in cardiac rhythm management and holds promise in treatment of variety of medical conditions such as reducing back pain, treatment of hypertension and obesity and curing diabetes without daily injections of insulin. In some situations implantable pulse generators are used to treat such conditions for which medicines either have not been completely effective or have shown some side effects.
This report contains market size and forecasts of Implantable Pulse Generator in global, including the following market information:
Global Implantable Pulse Generator Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Implantable Pulse Generator Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Implantable Pulse Generator companies in 2021 (%)
The global Implantable Pulse Generator market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Unipolar Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Implantable Pulse Generator include Medtronic, Boston Scientific Corporation, Abbott, Synapse Biomedical, Nevro Corporation, Neurosigma, Neuropace, Cyberonics and BioControl Medical. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Implantable Pulse Generator manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Implantable Pulse Generator Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Implantable Pulse Generator Market Segment Percentages, by Type, 2021 (%)
Unipolar
Multipolar
Global Implantable Pulse Generator Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Implantable Pulse Generator Market Segment Percentages, by Application, 2021 (%)
Hospitals
Ambulatory Surgical Centers
Home Care Settings
Clinics
Global Implantable Pulse Generator Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Implantable Pulse Generator Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Implantable Pulse Generator revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Implantable Pulse Generator revenues share in global market, 2021 (%)
Key companies Implantable Pulse Generator sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Implantable Pulse Generator sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
Boston Scientific Corporation
Abbott
Synapse Biomedical
Nevro Corporation
Neurosigma
Neuropace
Cyberonics
BioControl Medical
